P-088: Effect of rebamipide on colonic mucosal barrier of

P-088: Effect of rebamipide on colonic mucosal barrier of rebamipide Conclusions: Over a 4-week treatment course, esomeprazole and rebamipide combination therapy was more effective in decreasing the symptoms of reflux esophagitis rebamipide 100mg Rebamipide Tablet It is usually used to treat gastric ulcer and improve gastric mucosal lesion in acute gastritis

rebamipide In multivariate analysis, rebamipide was not inferior to PPI in preventing NSAID-induced serious GI complications

rebamipide Conclusion: Rebamipide 300 mg three times daily provides the prevention for low-dose aspirin-induced gastric hemorrhage and erythema in healthy Helicobacter Rebamipide (2-), a gastroprotective drug, has been clinically proven to effectively heal gastric